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Abstract. Plant cell cultures constitute a promise for the production of 
a high number of phytochemicals, although the majority of 
bioprocesses that have been developed so far have not resulted 
commercially successful. An overview indicates that most of the 
research carried out until now is of the empirical type. For this reason, 
there is a need for a rational approach to the molecular and cellular 
basis of metabolic pathways and their regulation in order to stimulate 
future advances. 
      The empirical investigations are based on the optimization of the 
culture system, exclusively considering input factors such as the 
selection of cellular lines, type and parameters of culture, bioreactor 
design and elicitor addition, and output factors such as cellular growth, 
the uptake system of nutrients, production and yield. In a rational 
approach towards the elucidation of taxol and related taxane 
production, our group has studied the relationship between the taxane 
profile and production and the expression of genes codifying for 
enzymes that participate in early, intermediate and late steps of their 
biosynthesis in elicited Taxus spp cell cultures. Our results show that  
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elicitors induce a dramatic reprogramming of gene expression in Taxus cell cultures, which 
likely accounts for the enhanced production of taxol and related taxanes and we have also 
determined some genes that control the main flux limiting steps. The application of 
metabolic engineering techniques for the production of taxol and taxanes of interest is also 
discussed.   
 
Introduction 
 
 One of the most important characteristics of plants is their ability to form 
compounds that, though not essential for completing the plant’s life cycle, are 
extremely useful for their adaptation to the environment. Many of these 
secondary compounds are considered of high value by the chemical and 
pharmaceutical industry due to their therapeutic and adaptogenic properties. 
It is estimated that 50% of drugs used in the preparation of medicines are 
natural products of plant secondary metabolism. Therefore, having been used 
as drugs since ancient times, by all the cultures ever to exist on our planet, 
plants remain an inexhaustible source of new medicines [1].  
 The natural exploitation of medicinal plants by means of their culture and 
extraction of their main active elements is fraught with geographical, 
environmental, economical and political risks and difficulties. So it is hardly 
surprising that one of the main objectives of plant biotechnology is the large-
scale production of secondary compounds with industrial applications. The 
biotechnological production of secondary metabolites using different in vitro 
techniques has been the focus of considerable research in recent years. 
Besides their use as pharmaceuticals, fragrances, colorants, aromatics and 
pesticides, secondary metabolites have recently been recognized as important 
disease-preventative ingredients in food, resulting in the term nutraceuticals [2]. 
 The advantages of this technological approach over conventional 
agriculture include: independence from geographical and seasonal variations 
and environmental factors as well as from political interference; a defined 
production system that ensures a continuous supply of products of uniform 
quality and quantity; the possibility of obtaining new compounds not 
originally formed in the cultivated plant; an efficient recovery of the product 
of interest; an extremely fast production and also stereo- and regiospecific 
biotransformations from inexpensive precursors.  
 Although in vitro culture of plant cells and tissues is routinely used in 
agriculture for plant breeding and micropropagation, its application in the 
commercial production of pharmaceuticals and other secondary compounds 
of interest is limited to only a few procedures [3-5]. 
 An essential requirement for the application of in vitro plant culture 
techniques in industrial-scale production of therapeutic compounds is that its 
cost is lower than culturing the intact plant or other procedures. Given the 
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complexity of these techniques, together with the costs involved in 
sterilization and use of bioreactors, the new technologies can only be 
assigned to the production of compounds of high added value.  
 Taxol (Fig. 1) is a secondary compound of great interest due to its wide 
spectrum of antineoplastic action. The main limitation to its therapeutic use is 
a limited supply from its natural source, the inner bark of Taxus species [6]. 
One of the most successful anticancer drugs to be developed in the past               
50 years, taxol produced by Bristol-Myers Squibb (BMS) reached worldwide 
sales of $1.5 billion in 1999. Although this company subsequently reported a 
24% decrease in taxol sales, from $422 millions in 2006 to $385 millions in 
2007 [BMS 2008 Annual Report], this reduction is primarily due to patent 
expiry and increased generic competition in Europe, as well as generic entry 
in Japan during the third quarter of 2006 [1]. The total market for taxol 
remains well above $1 billion per year [www.strategyr.com/Bulk Paclitaxel 
Market Report.asp] and continues to expand, with new clinical uses 
anticipated [7].  
 To combat the patent expiries, supergeneric versions of taxol, such as Cell 
Therapeutics’ Xyotax (polyglutamate paclitaxel) and Abraxis Oncology’s 
Abraxane (nanoparticle albumin-bound paclitaxel) have been developed, offering 
significant advantages over taxol in terms of adverse effects and drug delivery. 
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Figure 1. General structure of taxol and related taxoids. Ac: acetyl group; Ph: phenyl 
group. 
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Sales of Abraxane rose to $275 millions in 2009 [www.BioPortafolio.com: 
emerging oncology treatments: a focus on targeted therapeutics, supergeneric 
reformulations and supportive care] reflecting the growing market for taxol 
and its derivatives. Consequently, taxol and its semisynthetic precursors, 
including baccatin III, 10-deacetylbaccatin III and cephalomaninne (Fig. 1), 
are considered to be high added value secondary compounds. 
 Plant cell cultures constitute a promise and almost a reality for the 
controlled production of a considerable number of secondary compounds of 
interest, including taxol and its derivatives, although most of the bioprocesses 
developed up to now have not turned out to be commercially viable. Much of 
the research in this field carried out during the last decades has been 
empirical, concentrating on optimizing the culture system via known in-put 
factors (cell line selection, culture media, culture conditions, elicitors, 
bioreactor culture, etc.) and out-put factors (growth, production, yield, etc.) 
However, the most successful strategies and technologies depend on a 
rational approach to the molecular bioprocesses of plant cells, based on the 
understanding of biosynthetic pathways and their regulation.  
 
1. Empirical studies 
 
 Biotechnological production of taxol has been studied since the early 
1990s. Early work carried out by different research teams [8-10] showed that 
calli and cell suspensions obtained from young stems of Taxus sp. were able 
to produce taxol at least to the same extent as the intact plant. 
 In order to increase the productivity of taxol and related taxoids in cell 
and tissue cultures, various strategies, including optimisation of culture 
conditions, selection of high-producing cell lines, use of elicitors, and 
addition of precursors, have been examined by many researchers [11-18]. 
There are excellent reviews about the biotechnological production of taxol 
and current knowledge of its metabolism in cell cultures [19-25]. 
 
Establishment of Taxus spp. cell cultures 
 
 In order to obtain cell suspensions, initially on a small scale and then at 
bioreactor level, it is first necessary to establish fast-growing callus cultures 
from which the cell suspensions are derived. We obtained Taxus callus 
cultures from young stems of 3-4 year-old yew trees cultured in optimum 
conditions [26]. In order to develop a biotechnological system for an efficient 
taxol production, we optimized the culture conditions by assaying several 
basic media, plant growth regulators, sugar supplements, etc. As secondary 
metabolite production in plant cell cultures does not usually depend on 
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growth, a two-stage culture system was established. Plant cells are first 
cultured in a medium optimized for their growth, which is then replaced by a 
production medium that principally stimulates the biosynthesis of secondary 
metabolites [27]. This system has the added advantage of permitting the 
addition of biosynthetic precursors and elicitors when the secondary metabolite 
production is at its highest, that is, during the culture’s second stage. Taxol 
production was clearly enhanced by transferring cells from the optimum 
growth medium to the optimum medium for taxane production.  
 
Elicitor treatments 
 
 A high increase in taxol and baccatin III production was observed in the 
MeJ-supplemented culture medium of different T. baccata cell lines (Fig. 2). 
We have also supplemented the culture medium with a variety of                
elicitors, finding methyl jasmonate (MeJ) and coronatine (Cor) to be the most 
effective in promoting taxane biosynthesis and accumulation [27-31]. When 
comparing the maximum levels of taxane production in T. media cell cultures,  
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Figure 2. Taxol and baccatin III production in four different T. baccata cell lines 
treated with methyl jasmonate (MeJ, 100 μM) after 21 days of culture in the optimum 
medium for production.  
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we observed that the content of baccatin III in the Cor-treated cultures was           
21.6- and 4.8-fold higher than in the control and MeJ-treated cultures, 
respectively, whereas MeJ elicitation increased baccatin III production 4.5-
fold compared to the control. Taxol production under Cor treatment was 3.6- 
and 9.0-fold greater than in MeJ-treated and control cultures, respectively 
(Fig. 3) [31].  
 A notably high level of baccatin III accumulated in the Cor-treated cultures 
(52 mg/L) at day 16, when the productivity rate reached 3.3 mg L-1 day-1. This is 
a very promising result, since new taxol-related compounds with improved 
efficacy and less toxicity are currently being sought, and most of them are being 
obtained semisynthetically from the natural precursor baccatin III [25]. 
 
Total taxanes
0
20
40
60
80
100
1d 2d 4d 8d 12d 16d 20d 24d
Days
m
g/
L C
MeJ
Cor
m
g/
L
m
g/
L
 
 
Figure 3. Total taxane content (cell associated + extracellular) in the TXS cell line 
growing for 24 days in the production medium without (Control, C) and with 100 μM 
methyl jasmonate (MeJ) or 1 μM coronatine (Cor). Data are average values from three 
replicates ± SD. 
 
Scale-up to bioreactor culture  
 
 After optimizing the culture conditions, as well as environmental and 
physical factors, the next step for the profitable production of valuable 
secondary compounds is to scale up the culture. Bioreactors are used since 
they can be applied in large-scale production and allow a close control of 
culture conditions. The production of taxol and related taxanes in a variety of 
bioreactors has been described by several researchers [24, 32-34]. We 
compared the taxane levels achieved by T. media cell cultures grown in 
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Erlenmeyer flasks and a stirred bioreactor, in both cases using the same cell 
line and production medium supplemented with MeJ. Scaling up was found 
to improve the production of taxol and baccatin III 2.4- and 9 –fold, 
respectively (Fig. 4) [33].  
 Numerous studies have also reported that the immobilization of plant cell 
suspensions enhances the production of valuable plant metabolites [35-37]. 
This increase is probably due to the higher cell concentration, better cell-cell 
contact and more favorable conditions for cell differentiation.  
 In our case, taxol production clearly improved when cell suspensions 
were immobilized in 2% alginate beads and cultured in a bioreactor, using the 
optimum MeJ-supplemented medium for taxol biosynthesis. When taxol 
production was at its highest, at day 16, its levels were more than 5 times 
higher than those obtained by the same cell line growing freely in the same 
conditions (Fig. 5) [33]. 
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Figure 4. Total content (cell-associated + extracellular) of taxol and baccatin III in 
small-scale T. baccata cell cultures (Erlenmeyer flasks) and in a 5 L stirred bioreactor. 
In both cases cells were grown for 24 days in the optimum medium for production 
supplemented with methyl jasmonate (100 μM). 
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Figure 5. Configuration of a 5 L air-lift bioreactor used to culture T. baccata 
immobilized cells.  
 
2. Rational approach 
 
 In order to convert the potential of cell cultures into a commercial reality, 
after empirical optimization studies, a molecular approach is required, since it 
is necessary to know how the factors that improve production also affect 
molecular processes in producer cells, such as metabolic profiles, gene 
expression, enzymatic activity, etc.. These studies allow a better understanding 
of the biosynthetic pathways and their regulation. 
 The taxol biosynthetic pathway consists of 19 metabolic steps, 12 of 
which are known and have had their corresponding genes cloned and 
sequenced. The functions of the remaining 7 steps are understood, but the 
genes involved have not yet been sequenced [38-41].  
 In order to understand the limiting steps of the biosynthetic production of 
taxol, as well as its metabolic profile, it is necessary to compare the 
transcriptome of the known genes involved in taxol biosynthesis in both 
elicited and unelicited cultures [41-44]. 
 
Transcriptomic profiling 
 
 To investigate the elicitor mode of action in taxane biosynthesis and the 
relationship between gene expression and the pattern of taxane production, 
we used qRT-PCR to profile the expression of genes encoding enzymes 
involved in taxol biosynthesis in T. media cell cultures elicited with MeJ or 
Cor [31]. The studied genes and the enzymes they encode were: TXS 
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(taxadiene synthase) and T13αOH (taxadiene 13α-hydroxylase), both involved         
in early synthetic steps; T7βOH (taxane 7β-hydroxylase), T2αOH (taxane                  
2α-hydroxylase) and DBAT (10-deacetylbaccatin III-10β-O-acetyltransferase), 
which control intermediate synthetic steps; and PAM (phenylalanine 
aminomutase), BAPT (baccatin III-3-amino-13-phenylpropanoyltransferase) and 
DBTNBT (3’N-benzoyl transferase), which are involved in the last synthetic steps 
(Fig. 6).  
 Gene expression was determined from 1 h to 4 days after elicitation. 
Subsequent transcript accumulation is not shown in the figures because we 
observed that the highest expression and induction thereof occurs in this early 
period [42, 45]. Similar results have been reported by other research groups 
[41, 46]. 
 The expression of the TXS gene, which controls the first committed step 
of the taxol biosynthetic pathway [47], was greatly enhanced by the presence 
of elicitors in the culture medium (Fig. 7). Maximum TXS transcript levels in 
the Cor-elicited cultures were 4.8-fold higher than in the control, observed at 
24 h in both (Fig. 7). Although values were similar under both elicitors (140 
and 130 times higher than the reference value) (p<0.05), it is notable that TXS 
transcript levels peaked 3 days earlier in Cor-treated cultures. We had previously 
 
 
 
Figure 6. Taxol biosynthetic pathway. The enzymes controlling the steps discussed in 
the transcriptome study are highlighted with a circle.  
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shown that the TXS gene is highly induced in MeJ-elicited cell suspension 
cultures [42]. 
 Taxadiene-13α-hydroxylase (T13αOH) is the enzyme that hydroxylates 
taxa-4(20),11(12)-dien-5α-ol to taxa-4(20),11(12)-dien-5α-13α-diol [48]. As 
shown in Fig. 7, significantly higher transcript accumulation of this gene was 
observed in Cor- compared with MeJ-treated cultures (p>0.05), and in both 
elicited cultures compared with the control (p>0.05). Results obtained by 
Nims et al. [41] indicate that T13OH expression increases during the first hours 
after MeJ treatment. In our case, although RNAm accumulation was evident 
after 1 h of elicitation, the highest level was achieved after 4 days. The 
difference is probably due to the use of different cell lines and culture systems.   
 It is known that there is a branch point after the biosynthesis of taxa-
4(20),11(12)-dien-5α-ol, which can be the substrate either for an acetylation 
at C5OH and a subsequent hydroxylation at C10, or for an hydroxylation at 
C13 of the taxane skeleton, giving taxa-4(20),11(12)-dien-5α-acetoxy-10β-ol 
or taxa-4(20),11(12)-dien-5α-13α-diol, respectively (Fig. 6). Although we 
did not study the expression of genes (TAT and T10βOH) involved in the 
metabolic branch leading to taxa-4(20),11(12)-dien-5α-acetoxy-10β-ol, the 
high levels of the T13OH gene observed in our TXS cell line may suggest 
that, after elicitation with MeJ and Cor, taxol biosynthesis proceeds mainly 
through the step catalysed by the T13αOH enzyme. Nims et al. [41] also 
reported a preference for the T13αOH-side of the branch pathway in elicited 
T. cuspidata cell cultures, which confirms metabolic profiling data [49] 
showing that precursor flux leading to taxol is via 5α, 13α-diol through 
T13αOH, rather than 5α-yl-acetate derived from the alternative branch 
controlled by the TAT enzyme. 
 In the intermediate steps of taxol biosynthesis, the enzymes taxane-2α-
hydroxylase (T2αOH) and taxane-7β-hydroxylase (T7βOH) catalyse the 
hydroxylation at the 2C and 7C positions of the taxane skeleton, respectively 
[50, 51] (Fig. 6). The two corresponding genes showed similar expression 
patterns, which were comparable to that of the T13αOH gene (Fig. 7).  
 The expression of the DBAT gene, corresponding to the enzyme 
responsible for the transformation of 10-deacetylbaccatin III into baccatin III 
(Fig. 7) [52], in MeJ-and Cor-treated cell cultures was already very high at    
12 h, and continued increasing until days 1-2, decreasing thereafter to values 
similar to those observed at 12 h. The highest values observed in both 
cultures were 5 and 3 times higher, respectively, than in the control (Fig. 7). 
 The PAM gene, which encodes the enzyme responsible for the formation 
of β-phenylalanine from its isomer α-phenylalanine (Fig. 6) [53], is 
considered to be the first gene involved in the biosynthesis of the taxol lateral 
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chain. The expression of this gene in control cells remained very low 
throughout the 4 days of the study. In the elicited cultures (Fig. 7) two 
expression peaks were observed. The first occurred only 1 h after elicitation, 
with PAM transcript levels in the MeJ- and Cor-treated cultures being 43 and 
63 times higher, respectively, than the reference value. The second peak, 
which was the maximum PAM transcript level achieved, was observed at day 
4 under MeJ and day 2 under Cor treatment, being 52 and 93 times higher, 
respectively, than the reference value, and 29 and 53 times higher than in the 
control. It is notable that Cor was almost twice as effective as MeJ for the 
induction of the PAM gene.  
 In the final steps of the metabolic pathway (Fig. 6), the enzyme baccatin 
III 13-O-(3-amino-3-phenylpropanoyl) transferase (BAPT) [54] is responsible 
for binding the lateral chain to baccatin III, leading to taxanes with                
β-phenylalanine as a lateral chain. The enzyme N-benzoyl transferase 
(DBTNBT) [55] is involved in the last metabolic step leading to taxol. 
Control cultures grown in the production medium presented only a slight 
increase in the expression of the two corresponding genes over the 4 sampled 
days (Fig. 7). When comparing the elicitor treatments, the highest expression 
level of both genes was observed under MeJ, it being 1.3 times higher than 
the maximum under Cor. However, Cor caused an earlier activation, as 
shown in Fig. 7 (days 1-2 and 4, respectively). 
 Our results have shown that all the studied genes were induced to a variable 
extent by the presence of the elicitors MeJ (100 μM) and Cor (1 μM). The 
elicitors enhanced the expression of genes involved in the formation of the 
polyhydroxylated precursor of taxol and the phenylalanoyl CoA chain, but had a 
more limited effect on the last two steps of the taxol biosynthetic pathway (Figs. 
6 and 7). The elicited cultures clearly showed different taxane patterns and gene 
expression profiles, suggesting differing action mechanisms, despite the structural 
similarity of Cor and the active jasmonate JA-Ile.  
 Our metabolic studies have demonstrated that the presence of Cor in the 
culture medium dramatically enhanced taxane production, particularly of 
baccatin III and to a lower extent taxol, the highest levels of both taxanes 
being 4.8- and 3.6-fold greater than in the MeJ-elicited cultures, and without 
affecting cell growth. 
 Taken as a whole, our results show that both MeJ and Cor induce a 
dramatic reprogramming of gene expression in Taxus cell cultures, which likely 
accounts for the enhanced production of taxol and related taxanes. Compared 
with MeJ, Cor elicitation did not result in a significantly higher induction of the 
studied taxane biosynthetic genes but peak expression levels were generally 
observed earlier. The resulting earlier availability of precursors could be 
responsible for the higher amount of total taxanes achieved in cultures elicited 
by Cor rather than MeJ (3.3-fold higher, on average). 
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Figure 7. TXS, T 13-OH, T 2-OH, T 7-OH, DBAT, PAM, BAPT and DBTNBT gene 
expression in the TXS cell line cultured in the production media for 24 days under 
three different treatments: Control, 100 μM MeJ and 1 μM coronatine. GM: growth 
media; C: production media (control); Me: PM with MeJ; Co: PM with coronatine.  
 
 Determining the transcript profile of genes involved in taxol biosynthesis 
demonstrates that the presence of elicitors in the medium increases gene 
expression to varying degrees. The results also indicate that the transferases 
controlling the last steps of taxol biosynthesis probably also catalyze the 
GM C MeJ Cor
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limiting steps, and consequently are ideal targets for metabolic engineering 
techniques in the enhancement of taxol production. 
 
3. Metabolic engineering of Taxus 
 
 As Taxus species belong to the Gymnosperm class, they are very difficult 
to genetically transform. There have been many attempts to obtain 
transformed Taxus cell cultures using the Agrobacterium system or biolistic 
techniques, but with little success to date. In 1994, Han et al. [56] obtained 
gall cell lines after inoculating shoot segments of T. baccata and T. brevifolia 
with two strains of A. tumefaciens. In 2000, Furmanova and Syklowska-
Baranek [57] established transformed root cultures of T. x media by directly 
infecting several kinds of explants with three strains of A. rhizogenes.          
In 2005, Ho et al. [58] described taxol production in MeJ-elicited T. marei 
cell cultures harboring the gene that encodes the enzyme 10-deacetyl baccatin  
III-10-O-actyl transferase (DBAT). More recently, Zang et al. [59], in                
T. chinensis cell cultures overexpressing the same gene, obtained a taxol 
production 1.7 times higher than that achieved by the untransformed cells.    
By using particle bombardment-mediated transformation, Vongpaseuth et al. 
[60] have successfully obtained a transient transformation of Taxus spp. with 
the aim of characterizing the genes involved in taxol biosynthesis and its 
regulation. Following the same transformation methodology, Li et al. [61] 
obtained T. chinensis cell cultures overexpressing a 9-cis-epoxycarotenoid 
dioxygenase gene, which encodes a key enzyme in the biosynthesis of 
abscisic acid (ABA), a phytohormone involved in plant responses to different 
types of stress. The taxol production in these transformed cell cultures was 
found to be 2.7-fold higher compared with untransformed cultures.  However, 
apart from these studies, taxol production in transformed cell or root cultures 
has been scarcely explored. 
 We focused our attention on taxadiene synthase, the enzyme controlling 
the step that diverts GGPP from the metabolic pool to taxane biosynthesis, 
interested in gaining further insight into the key role it plays in taxane 
production overall. To this end, we established T. media cell cultures 
overexpressing the txs gene of T. baccata, but due to the difficulties of 
genetically transforming Taxus cell cultures with A. tumefaciens, we first 
obtained T. media transformed roots carrying this transgene (Fig. 8a), which 
were then dedifferentiated (Fig. 8b, c) [45]. Taxane production in the 
transformed cultures (Fig. 8d) was compared with an untransformed T. media 
cell line cultured in the same conditions. The highest taxane production was 
observed in the TXS cell line grown in the optimized production medium 
with MeJ (100 μM), it being 265% greater than in the untransformed control.
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Figure 8. Steps followed to establish transformed cell cultures from transformed root 
cultures. Total taxane production in the T. media transformed cell cultures overexpressing 
the txs gene of T. baccata. 
 
Notably, taxane levels as well as txs gene expression and TXS activity in 
both transformed and untransformed cell lines were clearly dependent on the 
elicitor action. 
 Knowledge of the genes involved in key steps of the taxol biosynthetic 
pathway and of how they are regulated, coupled with advanced metabolic 
engineering techniques, will allow transgenic cell cultures overexpressing 
target genes to be obtained, and will consequently lead to the establishment 
of highly productive cell cultures at an industrial level. We believe that our 
results could be useful for the development of rational strategies, including 
elicitation and metabolic engineering, to improve the yield of paclitaxel and 
the two related taxanes, 10-deacetylbaccatin III and baccatin III, which, as 
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previously mentioned, are used in the semisynthesis of the chemotherapeutic 
agent. 
 An aspect of taxane production that deserves highlighting is the 
mechanism of taxol excretion from cells, which could be enhanced by 
employing a two-phase culture system, so far not assayed in T. baccata cell 
suspensions. Future studies could combine an empirical and rational 
approach, assaying two-phase cultures to develop a biotechnological system 
for a high taxol production. 
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